Progression_Final_webBanner

The IO Revolution, Part 3 of 4: The Role of the Tumor in the Cancer Immunity Cycle

Part one of this four-part series looked at how host, tumor, and environmental factors shape tumor-immune system interactions. Part two further examined the role of the host, and in this blog, we consider the role of the tumor in the...

/ March 9, 2017
sequencingProbes_crop

Live sequencing with the Hyb & Seq™ platform at AGBT 2017

“We wanted to make the world’s simplest sequencer,” remarked Joe Beechem, Ph.D., Senior Vice President of R&D at NanoString. Beechem presented the Hyb & Seq platform with live demonstration during a lunchtime workshop at the 2017 annual meeting of Advances...

/ February 24, 2017
3Dbiology_Banner

3D Biology™ Technology Measures DNA, RNA, and Protein Simultaneously

3D Biology™ Technology* Measures DNA, RNA, and Protein Simultaneously, Preserving Samples By Joe Beechem, Senior Vice President of Research and Development *For Research Use Only. Not for use in Diagnostic Procedures Too often I see scientists struggling to understand their...

Role_of_the_Host_Full-width

The IO Revolution, Part 2 of 4: The Role of the Host in the Cancer Immunity Cycle

Part one of this four-part series looked at how host, tumor, and environmental factors shape tumor-immune system interactions. In the next few blogs, we will consider how each of these sources of inter-patient heterogeneity has the potential to influence the...

/ January 12, 2017
FGJJJ1 T lymphocytes and cancer cell. Coloured scanning electron micrograph (SEM) of T lymphocyte cells (smaller round cells) attached

Presidents, Rock Stars and Companion Diagnostics: 2016 Review of Immunotherapy

President Jimmy Carter announced this spring that he no longer needed treatments for the metastatic melanoma found in his brain–after treatment with pembrolizumab (Keytruda, Merck), his physicians could no longer detect the cancer. In 2016, high-profile success stories, the inclusion...

/ January 7, 2017